Akari Therapeutics plc ADS News
Latest updates and market news for AKTX
5 news
Dec 7 - Dec 13, 2025
Page 1
MT Newswires
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
➖
AI Sentiment
Neutral
5/10
GlobeNewswire
Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
European Equities Traded in the US as ADRs Little Changed in Monday Trading
➖
AI Sentiment
Neutral
5/10
Share this news page